Investegate |Intnl. Biotechnology Announcements | Intnl. Biotechnology: Correction: Half-year Report

Investegate announcements from Intnl. Biotechnology, Correction: Half-year Report

Related Keywords

Australia ,Cambridge ,Cambridgeshire ,United Kingdom ,Russia ,London ,City Of ,Ukraine ,Russian ,Australian ,Jim Horsburgh ,Vifor Pharma ,Patrick Maxwell ,Amgen ,Sv Health Investor ,Sv Health Investors ,Sv Health Investor Fund Vi ,Academy Of Medical Sciences ,Sv Fund ,Link Company Matters ,Nasdaq ,Pfizer ,Sv Health Managers ,Arena Pharmaceuticals ,United Kingdom Listing Authority Disclosure Guidance ,Securities Services United Kingdom ,Vertex Pharmaceuticals ,London Stock Exchange ,Company Financial ,Good Health ,Northern Trust Company ,Un Sustainable Development Goal ,Sv Biotech Crossover Opportunities Fund ,Half Yearly Financial ,Half Yearly Financial Report ,Yearly Report ,Fund Manager ,Investment Manager ,Annual General Meeting ,Investment Managers ,Non Executive Director ,Professor Patrick Maxwell ,Regius Professor ,Clinical Medicine ,Medical Sciences ,Eastern Europe ,Federal Reserve ,Focal Segmental Glomerulosclerosis ,Annual Report ,Development Goal ,London Stock ,Interim Report ,Financial Statements ,United Kingdom Listing Authority ,Disclosure Guidance ,Transparency Rule ,Responsibilities Statement ,Investegate Announcements ,Investegate Company Announcements ,Ntnl Biotechnology ,Egulatory News Service ,Egulatory News Service And Regulatory ,Ns ,